{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T23:25:46Z","timestamp":1780097146454,"version":"3.54.0"},"reference-count":79,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2005,1]]},"DOI":"10.1016\/j.jocn.2004.10.002","type":"journal-article","created":{"date-parts":[[2004,12,14]],"date-time":"2004-12-14T15:22:01Z","timestamp":1103037721000},"page":"6-11","source":"Crossref","is-referenced-by-count":53,"title":["Autotoxicity, methylation and a road to the prevention of Parkinson\u2019s disease"],"prefix":"10.1016","volume":"12","author":[{"given":"Adrian C.","family":"Williams","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B","family":"Ramsden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocn.2004.10.002_bib1","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/BF00314777","article-title":"Ecogenetics, xenobiotic biochemistry and neurological disease","volume":"238","author":"Williams","year":"1991","journal-title":"J Neurol"},{"key":"10.1016\/j.jocn.2004.10.002_bib2","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1136\/jnnp.56.9.943","article-title":"Hypersusceptibility to chemicals: risk factors for neurological disease?","volume":"56","author":"Williams","year":"1993","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jocn.2004.10.002_bib3","series-title":"Neurodegenerative diseases","first-page":"205","article-title":"Susceptibility to neurotoxins","author":"Williams","year":"1993"},{"key":"10.1016\/j.jocn.2004.10.002_bib4","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1749-6632.2001.tb05660.x","article-title":"Caloric restriction in primates and relevance to humans","volume":"928","author":"Roth","year":"2001","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.jocn.2004.10.002_bib5","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0165-1781(79)90006-4","article-title":"Chronic parkinsonism secondary to intravenous injection of meperidine analogues","volume":"1","author":"Davies","year":"1979","journal-title":"Psychiat Res"},{"key":"10.1016\/j.jocn.2004.10.002_bib6","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1126\/science.6823561","article-title":"Chronic parkinsonism in humans due to a product of meperidine-analog synthesis","volume":"219","author":"Langston","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.jocn.2004.10.002_bib7","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/0006-291X(84)91293-2","article-title":"Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase","volume":"120","author":"Chiba","year":"1984","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jocn.2004.10.002_bib8","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1073\/pnas.82.7.2173","article-title":"Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity","volume":"82","author":"Javitch","year":"1985","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jocn.2004.10.002_bib9","doi-asserted-by":"crossref","first-page":"7585","DOI":"10.1016\/S0021-9258(19)57434-8","article-title":"Energy-dependent uptake of N-methyl-4-phenylpyridinium, the neurotoxic metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, by mitochondria","volume":"261","author":"Ramsey","year":"1986","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jocn.2004.10.002_bib10","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1016\/0024-3205(85)90146-8","article-title":"Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine","volume":"36","author":"Nicklas","year":"1985","journal-title":"Life Sci"},{"key":"10.1016\/j.jocn.2004.10.002_bib11","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S1474-4422(03)00501-5","article-title":"The environment and Parkinson\u2019s disease: is the nigrostriatal system preferentially targeted by neurotoxins?","volume":"2","author":"Di Monte","year":"2003","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jocn.2004.10.002_bib12","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/81834","article-title":"Chronic systematic pesticide exposure reproduces features of Parkinson\u2019s disease","volume":"3","author":"Betarbet","year":"2000","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.jocn.2004.10.002_bib13","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/S0140-6736(98)03453-9","article-title":"Parkinson\u2019s disease, pesticides, and glutathione transferase polymorphisms","volume":"352","author":"Menegon","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.jocn.2004.10.002_bib14","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0304-3940(85)90411-2","article-title":"The toxic actions of MPTP and its metabolite MPP+ are not mimicked by analogues of MPTP lacking the N-methyl moiety","volume":"61","author":"Bradbury","year":"1985","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.jocn.2004.10.002_bib15","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/0006-8993(92)90576-U","article-title":"Indole-N-methylated \u03b2-carbolinium ions as potential brain-bioactivated neurotoxins","volume":"570","author":"Collins","year":"1992","journal-title":"Brain Res"},{"key":"10.1016\/j.jocn.2004.10.002_bib16","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1046\/j.1471-4159.1995.65062633.x","article-title":"1-Benzyl-1,2,3,4-tetrahydroisoquinoline as a parkinsonism-inducing agent: a novel endogenous amine in mouse brain and parkinsonian CSF","volume":"65","author":"Kotake","year":"1995","journal-title":"J Neurochem"},{"key":"10.1016\/j.jocn.2004.10.002_bib17","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/ana.410400120","article-title":"A dopaminergic neurotoxin, (R)-N-methylsalsolinol, increases in parkinsonian cerebrospinal fluid","volume":"40","author":"Maruyama","year":"1996","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jocn.2004.10.002_bib18","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1212\/WNL.45.12.2240","article-title":"\u03b2-Carbolinium cations, endogenous MPP+ analogs, in the lumber cerebrospinal fluid of parkinsonian patients","volume":"45","author":"Matsubara","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2004.10.002_bib19","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0168-0102(97)00083-7","article-title":"Isoquinoline neurotoxins in the brain and Parkinson\u2019s disease","volume":"29","author":"Nagatsu","year":"1997","journal-title":"Neurosci Res"},{"key":"10.1016\/j.jocn.2004.10.002_bib20","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/0304-3940(88)90166-8","article-title":"An endogenous substrate of brain, tetrahydroisoquinoline, produces parkinsonism in primates with decreased dopamine, tyrosine hydroxylase and biopterin in the nigrostriatal regions","volume":"87","author":"Nagatsu","year":"1988","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.jocn.2004.10.002_bib21","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/0006-291X(89)91371-5","article-title":"A N-methyl-transferase in human brain catalyses N-methylation of 1,2,3,4-tetrahydroisoquinoline, a precursor of a dopaminergic neurotoxin, N-methylisoquinolinium ion","volume":"161","author":"Naoi","year":"1989","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jocn.2004.10.002_bib22","first-page":"212","article-title":"N-methylated tetrahydroisoquinolines as dopaminergic neurotoxins","volume":"60","author":"Naoi","year":"1993","journal-title":"Adv Neurol"},{"issue":"Suppl","key":"10.1016\/j.jocn.2004.10.002_bib23","first-page":"197","article-title":"Novel toxins and Parkinson\u2019s disease: N-methylation and oxidation as metabolic bioactivation of neurotoxin","volume":"41","author":"Naoi","year":"1994","journal-title":"J Neural Transm"},{"key":"10.1016\/j.jocn.2004.10.002_bib24","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/ana.410430211","article-title":"(R)-Salsolinol N-methyltransferase activity increases in parkinsonian lymphocytes","volume":"43","author":"Naoi","year":"1998","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jocn.2004.10.002_bib25","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0304-3940(00)01723-7","article-title":"Nicotinamide N-methyl-transferase is higher in the lumbar cerebrospinal fluid of patients with Parkinson\u2019s disease","volume":"298","author":"Akoyama","year":"2001","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.jocn.2004.10.002_bib26","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1111\/j.1471-4159.1990.tb05809.x","article-title":"Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson\u2019s disease","volume":"55","author":"Schapira","year":"1990","journal-title":"J Neurochem"},{"key":"10.1016\/j.jocn.2004.10.002_bib27","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.1016\/0006-2952(86)90436-3","article-title":"Role of N-methyl-transferases in the neurotoxicity associated with the metabolites of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and other 4-substituted pyridines in the environment","volume":"35","author":"Ansher","year":"1986","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jocn.2004.10.002_bib28","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S0165-6147(03)00078-6","article-title":"Nicotinamide: necessary nutrient emerges as a novel cytoprotectant for the brain","volume":"24","author":"Maise","year":"2003","journal-title":"Trend Pharmacol Sci"},{"issue":"Suppl 3","key":"10.1016\/j.jocn.2004.10.002_bib29","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/ana.10479","article-title":"Bioenergetic approaches for neuroprotection in Parkinson\u2019s disease","volume":"53","author":"Beal","year":"2003","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jocn.2004.10.002_bib30","unstructured":"Cartwright L, Williams AC, Ramsden DB. Nicotinamide: neuroprotective effects against dopamine and MPP+. In: Proceedings of the Global College of Neuroprotection and Neuroregeneration, Annual Conference 2004, Zermatt"},{"key":"10.1016\/j.jocn.2004.10.002_bib31","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/0140-6736(91)90113-4","article-title":"N-methylation of pyridines in Parkinson\u2019s disease","volume":"338","author":"Green","year":"1991","journal-title":"Lancet"},{"issue":"Suppl 136","key":"10.1016\/j.jocn.2004.10.002_bib32","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1600-0404.1991.tb05015.x","article-title":"Metabolic biomarkers of Parkinson\u2019s disease","volume":"84","author":"Williams","year":"1991","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.jocn.2004.10.002_bib33","first-page":"716","article-title":"The MPTP tale: pathway to prevention of Parkinson\u2019s disease?","volume":"49","author":"Williams","year":"1993","journal-title":"Br J Hosp Med"},{"key":"10.1016\/j.jocn.2004.10.002_bib34","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s007020070047","article-title":"N-Methylation ability for azaheterocyclic amines is higher in Parkinson\u2019s disease: nicotinamide loading test","volume":"107","author":"Aoyama","year":"2000","journal-title":"J Neural Transm"},{"key":"10.1016\/j.jocn.2004.10.002_bib35","doi-asserted-by":"crossref","first-page":"299S","DOI":"10.1042\/bst021299s","article-title":"Neurotoxicity of nicotinamide derivatives; their role in the aetiology of Parkinson\u2019s disease","volume":"21","author":"Willets","year":"1993","journal-title":"Biochem Soc Transact"},{"key":"10.1016\/j.jocn.2004.10.002_bib36","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1078\/0940-2993-00214","article-title":"Possible role of 1-methylnicotinamide in the pathogenesis of Parkinson\u2019s disease","volume":"53","author":"Fukushima","year":"2002","journal-title":"Exp Toxic Pathol"},{"key":"10.1016\/j.jocn.2004.10.002_bib37","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/jnr.490420313","article-title":"Radical formation site of cerebral complex 1 and Parkinson\u2019s disease","volume":"42","author":"Fukushima","year":"1995","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.jocn.2004.10.002_bib38","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/j.1471-4159.1979.tb09919.x","article-title":"Niacin and niacinamide transport in the central nervous system. In vivo studies","volume":"33","author":"Spector","year":"1979","journal-title":"J Neurochem"},{"key":"10.1016\/j.jocn.2004.10.002_bib39","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/S0140-6736(05)70284-1","article-title":"N-methyl-(R)-salsolinol and its relevance to Parkinson\u2019s disease","volume":"351","author":"Gerlach","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.jocn.2004.10.002_bib40","first-page":"215","article-title":"The aetiology of idiopathic Parkinson\u2019s disease: a genetic and environmental model","volume":"80","author":"Williams","year":"1999","journal-title":"Adv Neurol"},{"key":"10.1016\/j.jocn.2004.10.002_bib41","first-page":"105","article-title":"Further studies in xenobiotic metabolism and Parkinson\u2019s disease","volume":"86","author":"Ramsden","year":"2001","journal-title":"Adv Neurol"},{"key":"10.1016\/j.jocn.2004.10.002_bib42","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/jnen\/61.2.111","article-title":"Expression of nicotinamide N-methyltransferase (E.C. 2.1.1.1) in the Parkinsonian brain","volume":"61","author":"Parsons","year":"2002","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.jocn.2004.10.002_bib43","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0304-3940(03)00218-0","article-title":"High expression of nicotinamide N-methyltransferase in patients with idiopathic Parkinson\u2019s disease","volume":"342","author":"Parsons","year":"2003","journal-title":"Neurosci Lett"},{"issue":"Suppl 3","key":"10.1016\/j.jocn.2004.10.002_bib44","first-page":"283","article-title":"S-adenosylmethionine in cerebrospinal fluid in Parkinson\u2019s disease (Abstract)","volume":"42","author":"Pall","year":"1992","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2004.10.002_bib45","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0304-3940(01)01972-3","article-title":"Decrease of methionine and S-adenosylmethionine and increase of homocysteine in treated patients with Parkinson\u2019s disease","volume":"308","author":"M\u00fcller","year":"2001","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.jocn.2004.10.002_bib46","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/BF02815143","article-title":"Striatal dopamine depletion, tremors, and hypokinesia following the intracranial injection of S-adenosylmethionine: a possible role of hypermethylation in Parkinsonism","volume":"26","author":"Charlton","year":"1995","journal-title":"Mol Chem Neuropathol"},{"key":"10.1016\/j.jocn.2004.10.002_bib47","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1146\/annurev.pharmtox.39.1.19","article-title":"Methylation pharmacogenetics: catechol O-methyltransferase, thiopurine methyltransferase, and histamine N-methyltransferase","volume":"39","author":"Weinshilboum","year":"1999","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.jocn.2004.10.002_bib48","first-page":"238","article-title":"A direct correlation between nicotinamide N-methyltransferase activity and protein levels in the human liver cytosol","volume":"1422","author":"Smith","year":"1998","journal-title":"Biochem Biophys Acta"},{"key":"10.1016\/j.jocn.2004.10.002_bib49","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1001\/jama.283.20.2674","article-title":"Association of coffee and caffeine intake with the risk of Parkinson\u2019s disease","volume":"283","author":"Ross","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.jocn.2004.10.002_bib50","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/ana.1052","article-title":"Prospective study of caffeine consumption and risk of Parkinson\u2019s disease in men and women","volume":"50","author":"Ascherio","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jocn.2004.10.002_bib51","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2188\/jea.11.87","article-title":"Meta-analysis for epidemiologic studies on the relationship between smoking and Parkinson\u2019s disease","volume":"11","author":"Sugita","year":"2001","journal-title":"J Epidemiol"},{"key":"10.1016\/j.jocn.2004.10.002_bib52","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1212\/WNL.45.6.1041","article-title":"Cigarette smoking and protection from Parkinson\u2019s disease: false association or etiologic clue?","volume":"45","author":"Morens","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2004.10.002_bib53","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1212\/WNL.52.1.115","article-title":"Smoking and Parkinson\u2019s disease: a dose\u2013response relationship","volume":"52","author":"Gorell","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2004.10.002_bib54","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1212\/WNL.58.4.581","article-title":"Smoking and Parkinson\u2019s disease in twins","volume":"58","author":"Tanner","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2004.10.002_bib55","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1001\/jama.283.20.2674","article-title":"Association of coffee and caffeine intake with the risk of Parkinson disease","volume":"283","author":"Ross","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.jocn.2004.10.002_bib56","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1212\/WNL.55.9.1350","article-title":"Smoking, alcohol, and coffee consumption preceding Parkinson\u2019s disease: a case-control study","volume":"55","author":"Benedetti","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2004.10.002_bib57","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1212\/WNL.47.3.644","article-title":"Diet and Parkinson\u2019s disease II: a possible role for the past intake of specific nutrients. Results from a self-administered food-frequency questionnaire in a case-control study","volume":"47","author":"Hellenbrand","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2004.10.002_bib58","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/1531-8257(199901)14:1<28::AID-MDS1007>3.0.CO;2-O","article-title":"Nutritional and occupational factors influencing the risk of Parkinson\u2019s disease: a case-control study in southeastern Sweden","volume":"14","author":"Fall","year":"1999","journal-title":"Movement Disord"},{"key":"10.1016\/j.jocn.2004.10.002_bib59","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1159\/000110318","article-title":"Worldwide occurrence of Parkinson\u2019s disease: an updated review","volume":"12","author":"Zhang","year":"1993","journal-title":"Neuroepidemiol"},{"key":"10.1016\/j.jocn.2004.10.002_bib60","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1212\/WNL.55.9.1358","article-title":"Parkinson\u2019s disease and parkinsonism in a longitudinal study: twofold higher incidence in men. ILSA working group. Italian Longitudinal Study on Ageing","volume":"55","author":"Baldereschi","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2004.10.002_bib61","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the \u03b1-synuclein gene identified in families with Parkinson\u2019s disease","volume":"276","author":"Polymeropoulos","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.jocn.2004.10.002_bib62","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0304-3940(02)01178-3","article-title":"\u03b1-Synuclein promoter and risk of Parkinson\u2019s disease: microsatellite and allelic size variability","volume":"336","author":"Tan","year":"2003","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.jocn.2004.10.002_bib63","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/33416","article-title":"Mutations in the Parkin gene causes autosomal recessive juvenile parkinsonism","volume":"392","author":"Kitada","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.jocn.2004.10.002_bib64","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1126\/science.1077209","article-title":"Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism","volume":"299","author":"Bonifati","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.jocn.2004.10.002_bib65","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1212\/WNL.53.8.1858","article-title":"Case-control study of the ubiquitin carboxy-terminal hydrolase L1 gene in Parkinson\u2019s disease","volume":"53","author":"Maraganore","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2004.10.002_bib66","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/26652","article-title":"The ubiquitin pathway in Parkinson\u2019s disease","volume":"395","author":"Leroy","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.jocn.2004.10.002_bib67","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S1474-4422(03)00350-8","article-title":"Genes and parkinsonism","volume":"2","author":"Hardy","year":"2003","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jocn.2004.10.002_bib68","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1126\/science.1096284","article-title":"Hereditary Early-onset Parkinson\u2019s disease caused by mutations in PINK1","volume":"304","author":"Valente","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.jocn.2004.10.002_bib69","doi-asserted-by":"crossref","first-page":"14524","DOI":"10.1073\/pnas.172514599","article-title":"Resistance of \u03b1-synuclein null mice to the parkinsonian neurotoxin MPTP","volume":"99","author":"Dauer","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jocn.2004.10.002_bib70","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1046\/j.1471-4159.2000.740721.x","article-title":"\u03b1-Synuclein up-regulation in substantia nigra dopaminergic neurons following administration of the parkinsonian toxin MPTP","volume":"74","author":"Vila","year":"2000","journal-title":"J Neurochem"},{"issue":"Suppl","key":"10.1016\/j.jocn.2004.10.002_bib71","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/978-3-7091-6842-4_10","article-title":"N-methyl-(R)-salsolinol as a dopaminergic neurotoxin: from an animal model to an early marker of Parkinson\u2019s disease","volume":"50","author":"Naoi","year":"1997","journal-title":"J Neural Transm"},{"key":"10.1016\/j.jocn.2004.10.002_bib72","series-title":"Pellagra In Nutritional Disorders of the Nervous System","author":"Spillane","year":"1947"},{"issue":"8659","key":"10.1016\/j.jocn.2004.10.002_bib73","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S0140-6736(89)90538-2","article-title":"S-methylation in motor neuron disease and Parkinson\u2019s disease","volume":"2","author":"Waring","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.jocn.2004.10.002_bib74","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.3109\/00498259409043298","article-title":"D-Penicillamine metabolism in neurodegenerative diseases: an in vivo\/in vitro sulphydryl methylation study","volume":"24","author":"Peters","year":"1994","journal-title":"Xenobiotica"},{"key":"10.1016\/j.jocn.2004.10.002_bib75","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/00001648-200205000-00012","article-title":"Lead exposure and amyotrophic lateral sclerosis","volume":"13","author":"Kamel","year":"2002","journal-title":"Epidemiol"},{"key":"10.1016\/j.jocn.2004.10.002_bib76","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1055\/s-2001-15260","article-title":"Amyotrophic lateral sclerosis: pathogenesis","volume":"21","author":"Brown","year":"2001","journal-title":"Semin Neurol"},{"key":"10.1016\/j.jocn.2004.10.002_bib77","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1212\/WNL.42.7.1336","article-title":"Content of the neurotoxins cycasin (methylazoxymethanol \u03b2-D-glucoside) and BMAA (\u03b2-N-methylamino-L-alanine) in cycad flour prepared by Guam Chamorros","volume":"42","author":"Kisby","year":"1992","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2004.10.002_bib78","doi-asserted-by":"crossref","first-page":"20c","DOI":"10.1042\/bj0980020C","article-title":"Studies on methylazoxymethanol, the aglycone of cycasin: methylation of nucleic acids in vitro","volume":"98","author":"Matsumoto","year":"1996","journal-title":"Biochem J"},{"key":"10.1016\/j.jocn.2004.10.002_bib79","unstructured":"Kisby GE, Nottingham V, Kaytor R. Brain metabolism of \u03b2-N-methylamino-L-alanine (BMAA) and protection of excito-toxicity by GABA uptake inhibitors (Abstract). In: Proceedings of the Society of Neuroscience Annual Meeting. Abstract 18.82; 1992"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586804003376?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586804003376?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T09:00:47Z","timestamp":1625130047000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586804003376"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":79,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["S0967586804003376"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2004.10.002","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2005,1]]}}}